In the last 12 months, insiders at Protalix BioTherapeutics made open-market purchases of $101,360 (56K shares) and open-market sales of $314 (168 shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Eyal Rubin | Sr. Vp And Cfo | 0 | 660,909 | 660,909 | 56.8% | 05 Nov, 2024 |
| 2 | Yaron Naos | Sr. Vp, Operations | 0 | 225,817 | 225,817 | 19.4% | 04 Sep, 2025 |
| 3 | Dror Bashan | President And Ceo | 188,516 | 0 | 188,516 | 16.2% | 23 Dec, 2025 |
| 4 | Yael Hayon | Vp, Research Development | 0 | 35,115 | 35,115 | 3.0% | 17 Aug, 2023 |
| 5 | Eliot Forster | Director | 0 | 7,500 | 7,500 | 0.6% | 04 Sep, 2025 |
| 6 | Zvi Shmuel Ben | Director | 0 | 7,500 | 7,500 | 0.6% | 04 Sep, 2025 |
| 7 | Amos Bar-Shalev | Director | 0 | 7,500 | 7,500 | 0.6% | 04 Sep, 2025 |
| 8 | Christian Elze | Director | 0 | 7,500 | 7,500 | 0.6% | 04 Sep, 2025 |
| 9 | Pol F Boudes | Director | 0 | 7,500 | 7,500 | 0.6% | 04 Sep, 2025 |
| 10 | Gwen A Melincoff | Director | 0 | 7,500 | 7,500 | 0.6% | 04 Sep, 2025 |
| 11 | Aharon Schwartz | Director | 0 | 7,500 | 7,500 | 0.6% | 04 Sep, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 03 Sep, 2026 | Aharon Schwartz | Director | Acquired A | 17,000 | $0.00 | $0 | 17,000 | Direct |
| 03 Sep, 2026 | Aharon Schwartz | Director | Acquired A | 8,500 | $0.00 | $0 | 8,500 | Direct |
| 03 Sep, 2026 | Dror Bashan | President And Ceo | Acquired A | 320,000 | $0.00 | $0 | 320,000 | Direct |
| 03 Sep, 2026 | Christian Elze | Director | Acquired A | 17,000 | $0.00 | $0 | 17,000 | Direct |
| 03 Sep, 2026 | Pol F Boudes | Director | Acquired A | 17,000 | $0.00 | $0 | 17,000 | Direct |
| 03 Sep, 2026 | Christian Elze | Director | Acquired A | 8,500 | $0.00 | $0 | 8,500 | Direct |
| 03 Sep, 2026 | Pol F Boudes | Director | Acquired A | 8,500 | $0.00 | $0 | 8,500 | Direct |
| 03 Sep, 2026 | Dror Bashan | President And Ceo | Acquired A | 160,000 | $0.00 | $0 | 160,000 | Direct |
| 03 Sep, 2026 | Zvi Shmuel Ben | Director | Acquired A | 17,000 | $0.00 | $0 | 17,000 | Direct |
| 03 Sep, 2026 | Gwen A Melincoff | Director | Acquired A | 17,000 | $0.00 | $0 | 17,000 | Direct |
| 03 Sep, 2026 | Yaron Naos | Sr. Vp Coo | Acquired A | 112,000 | $0.00 | $0 | 112,000 | Direct |
| 03 Sep, 2026 | Eliot Forster | Director | Acquired A | 17,000 | $0.00 | $0 | 17,000 | Direct |
| 03 Sep, 2026 | Eliot Forster | Director | Acquired A | 8,500 | $0.00 | $0 | 8,500 | Direct |
| 03 Sep, 2026 | Gwen A Melincoff | Director | Acquired A | 8,500 | $0.00 | $0 | 8,500 | Direct |
| 03 Sep, 2026 | Yaron Naos | Sr. Vp Coo | Acquired A | 56,000 | $0.00 | $0 | 56,000 | Direct |
| 03 Sep, 2026 | Zvi Shmuel Ben | Director | Acquired A | 8,500 | $0.00 | $0 | 8,500 | Direct |
| 03 Sep, 2026 | Amos Bar-Shalev | Director | Acquired A | 17,000 | $0.00 | $0 | 17,000 | Direct |
| 03 Sep, 2026 | Amos Bar-Shalev | Director | Acquired A | 8,500 | $0.00 | $0 | 8,500 | Direct |
| 19 Dec, 2025 | Dror Bashan | President And Ceo | Acquired P | 56,000 | $1.81 | $101.36K | 188,516 | Direct |
| 18 Nov, 2025 | Amos Bar-Shalev | Director | Disposed S | 168 | $1.87 | $314 | 0 | Direct |